Sana Biotechnology, Inc. (SANA)
NASDAQ: SANA · Real-Time Price · USD
3.930
+0.380 (10.70%)
At close: Feb 6, 2026, 4:00 PM EST
4.000
+0.070 (1.78%)
After-hours: Feb 6, 2026, 7:57 PM EST
Sana Biotechnology Market Cap
Sana Biotechnology has a market cap or net worth of $1.05 billion as of February 6, 2026. Its market cap has increased by 34.34% in one year.
Market Cap
1.05B
Enterprise Value
983.50M
1-Year Change
34.34%
Ranking
Category
Stock Price
$3.93
Market Cap Chart
Since the IPO on February 4, 2021, Sana Biotechnology's market cap has decreased from $1.33B to $1.05B, a decrease of -21.00%. That is a compound annual growth rate of -4.60%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 6, 2026 | 1.05B | -3.44% |
| Dec 31, 2025 | 1.08B | 197.89% |
| Dec 31, 2024 | 363.93M | -54.75% |
| Dec 29, 2023 | 804.30M | 7.21% |
| Dec 30, 2022 | 750.19M | -73.52% |
| Dec 31, 2021 | 2.83B | 113.84% |
| Feb 4, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ventyx Biosciences | 1.00B |
| Theravance Biopharma | 992.17M |
| Phathom Pharmaceuticals | 971.64M |
| ORIC Pharmaceuticals | 970.00M |
| Vir Biotechnology | 962.75M |
| UroGen Pharma | 960.52M |
| ARS Pharmaceuticals | 955.87M |
| Iovance Biotherapeutics | 936.84M |